These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 22030266)

  • 1. A study of a family with the skeletal muscle RYR1 mutation (c.7354C>T) associated with central core myopathy and malignant hyperthermia susceptibility.
    Taylor A; Lachlan K; Manners RM; Lotery AJ
    J Clin Neurosci; 2012 Jan; 19(1):65-70. PubMed ID: 22030266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces?
    Mathews KD; Moore SA
    Arch Neurol; 2004 Jan; 61(1):27-9. PubMed ID: 14732615
    [No Abstract]   [Full Text] [Related]  

  • 3. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
    Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
    Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autosomal dominant congenital myopathy with cores and rods is associated with a neomutation in the RYR1 gene encoding the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Nivoche Y; Qi D; MacLennan DH; Fardeau M; Lunardi J
    Hum Mol Genet; 2000 Nov; 9(18):2599-608. PubMed ID: 11063719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in RYR1 in malignant hyperthermia and central core disease.
    Robinson R; Carpenter D; Shaw MA; Halsall J; Hopkins P
    Hum Mutat; 2006 Oct; 27(10):977-89. PubMed ID: 16917943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core myopathies and malignant hyperthermia susceptibility: a review.
    Brislin RP; Theroux MC
    Paediatr Anaesth; 2013 Sep; 23(9):834-41. PubMed ID: 23617272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization.
    Guis S; Figarella-Branger D; Monnier N; Bendahan D; Kozak-Ribbens G; Mattei JP; Lunardi J; Cozzone PJ; Pellissier JF
    Arch Neurol; 2004 Jan; 61(1):106-13. PubMed ID: 14732627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound RYR1 heterozygosity resulting in a complex phenotype of malignant hyperthermia susceptibility and a core myopathy.
    Kraeva N; Heytens L; Jungbluth H; Treves S; Voermans N; Kamsteeg E; Ceuterick-de Groote C; Baets J; Riazi S
    Neuromuscul Disord; 2015 Jul; 25(7):567-76. PubMed ID: 25958340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild clinical and histopathological features in patients who carry the frequent and causative malignant hyperthermia RyR1 mutation p.Thr2206Met.
    Rueffert H; Wehner M; Ogunlade V; Meinecke C; Schober R
    Clin Neuropathol; 2009; 28(6):409-16. PubMed ID: 19919814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
    Monnier N; Kozak-Ribbens G; Krivosic-Horber R; Nivoche Y; Qi D; Kraev N; Loke J; Sharma P; Tegazzin V; Figarella-Branger D; Roméro N; Mezin P; Bendahan D; Payen JF; Depret T; Maclennan DH; Lunardi J
    Hum Mutat; 2005 Nov; 26(5):413-25. PubMed ID: 16163667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Samaritan myopathy, an ultimately benign congenital myopathy, is caused by a RYR1 mutation.
    Böhm J; Leshinsky-Silver E; Vassilopoulos S; Le Gras S; Lerman-Sagie T; Ginzberg M; Jost B; Lev D; Laporte J
    Acta Neuropathol; 2012 Oct; 124(4):575-81. PubMed ID: 22752422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.
    Jungbluth H; Davis MR; Müller C; Counsell S; Allsop J; Chattopadhyay A; Messina S; Mercuri E; Laing NG; Sewry CA; Bydder G; Muntoni F
    Neuromuscul Disord; 2004 Dec; 14(12):785-90. PubMed ID: 15564033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant and recessive RYR1 mutations in adults with core lesions and mild muscle symptoms.
    Duarte ST; Oliveira J; Santos R; Pereira P; Barroso C; Conceição I; Evangelista T
    Muscle Nerve; 2011 Jul; 44(1):102-8. PubMed ID: 21674524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
    Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
    Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central core disease due to recessive mutations in RYR1 gene: is it more common than described?
    Kossugue PM; Paim JF; Navarro MM; Silva HC; Pavanello RC; Gurgel-Giannetti J; Zatz M; Vainzof M
    Muscle Nerve; 2007 May; 35(5):670-4. PubMed ID: 17226826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RYR1-Related Myopathies: Clinical, Histopathologic and Genetic Heterogeneity Among 17 Patients from a Portuguese Tertiary Centre.
    Samões R; Oliveira J; Taipa R; Coelho T; Cardoso M; Gonçalves A; Santos R; Melo Pires M; Santos M
    J Neuromuscul Dis; 2017; 4(1):67-76. PubMed ID: 28269792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core myopathies and risk of malignant hyperthermia.
    Klingler W; Rueffert H; Lehmann-Horn F; Girard T; Hopkins PM
    Anesth Analg; 2009 Oct; 109(4):1167-73. PubMed ID: 19762745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene.
    Fischer D; Herasse M; Ferreiro A; Barragán-Campos HM; Chiras J; Viollet L; Maugenre S; Leroy JP; Monnier N; Lunardi J; Guicheney P; Fardeau M; Romero NB
    Neurology; 2006 Dec; 67(12):2217-20. PubMed ID: 17190947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.